Oncology remains one of the most active and innovative areas of biopharma research and accounts for the largest share of global clinical development activity. Advances in cancer biology, biomarker-driven patient selection, precision oncology, and novel therapeutic modalities have changed the landscape over the past few years, presenting new opportunities to tackle previously difficult-to-treat malignancies. Both, […] The post Oncology Trends: Clinical Trial Activity and Innovation Shifts in 2024–2025 appeared first on Allucent .